Page last updated: 2024-10-28

glipizide and Arrhythmia

glipizide has been researched along with Arrhythmia in 2 studies

Glipizide: An oral hypoglycemic agent which is rapidly absorbed and completely metabolized.
glipizide : An N-sulfonylurea that is glyburide in which the (5-chloro-2-methoxybenzoyl group is replaced by a (5-methylpyrazin-2-yl)carbonyl group. An oral hypoglycemic agent, it is used in the treatment of type 2 diabetes mellitus.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Leonard, CE1
Brensinger, CM1
Aquilante, CL1
Bilker, WB1
Boudreau, DM1
Deo, R1
Flory, JH1
Gagne, JJ1
Mangaali, MJ1
Hennessy, S1
Ballagi-Pordány, G1
Köszeghy, A1
Koltai, MZ1
Aranyi, Z1
Pogátsa, G1

Other Studies

2 other studies available for glipizide and Arrhythmia

ArticleYear
Comparative Safety of Sulfonylureas and the Risk of Sudden Cardiac Arrest and Ventricular Arrhythmia.
    Diabetes care, 2018, Volume: 41, Issue:4

    Topics: Aged; Arrhythmias, Cardiac; Cause of Death; Death, Sudden, Cardiac; Diabetic Angiopathies; Female; G

2018
Divergent cardiac effects of the first and second generation hypoglycemic sulfonylurea compounds.
    Diabetes research and clinical practice, 1990, Volume: 8, Issue:2

    Topics: Animals; Arrhythmias, Cardiac; Blood Glucose; Carbutamide; Dose-Response Relationship, Drug; Electro

1990